A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer

Neora Yaal-Hahoshen, Yair Maimon, Nava Siegelmann-Danieli, Shahar Lev-Ari, Ilan G. Ron, Fani Sperber, Noah Samuels, Jacob Shoham, Ofer Merimsky

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science